Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan

• Yasuo Yanagi,
• Kanji Takahashi,
• Tomohiro Iida,
• Fumi Gomi,
• Junko Morii,
• Eriko Kunikane,
• Taiji Sakamoto

Affiliations

Yasuo Yanagi

Department of Ophthalmology and Microtechnology, Yokohama City University

Kanji Takahashi

Department of Ophthalmology, Kansai Medical University

Tomohiro Iida

Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine

Fumi Gomi

Department of Ophthalmology, Hyogo Medical University

Junko Morii

IQVIA Solutions Japan, K.K.

Eriko Kunikane

Senju Pharmaceutical Co., Ltd.

Taiji Sakamoto

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences